Role Summary
Exec Director, Regulatory Affairs-Combination Products & Devices responsible for defining and driving global regulatory strategies for combination products and devices, ensuring alignment with corporate goals and regulatory expectations. Lead regulatory excellence across global markets, influence cross-functional decision-making in a matrixed environment, and provide strategic direction for late-stage development programs and regulatory submissions.
Responsibilities
- Strategic Leadership & Vision: Define and drive global regulatory strategies for combination products, champion regulatory innovation, and guide development and regulatory paths for combination products and devices.
- Global Regulatory Excellence: Lead the development of global CMC regulatory initiatives for combination products and devices, ensuring conformance and compliance across markets.
- Enterprise Collaboration & Influence: Build collaborative relationships across Quality, Manufacturing, Technical Development, Clinical Development, and Supply Chain; influence cross-functional regulatory planning in a matrixed environment.
- Program Oversight & Governance: Provide strategic direction for late-stage development programs, guide packaging and development teams, and lead major regulatory applications and lifecycle management strategies.
- Regulatory Operations & Submissions: Oversee drafting, review, and approval of CMC sections for regulatory filings; lead agency interactions, inspections, and regulatory responses; ensure readiness for global commercialization.
- Design Control & Technical Strategy: Contribute to Design Control processes and documentation, align with FDA 21 CFR Part 4 and global standards; support design history files, human factors studies, and process characterization.
- Leadership & Culture: Model company values and foster a culture of integrity, excellence, and continuous improvement within the global CMC RA organization.
Qualifications
- A scientific degree with directly relevant professional experience in small molecule and biologics development, global CMC regulatory affairs and CMC technical areas of at least 16 years with a BA/BS or 14 years with an MA/MS, PhD, PharmD, or MD.
- Demonstrated track record in leading CMC regulatory affairs initiatives, innovative CMC regulatory strategies, and leadership in international regulatory/industry forums for topics of external policy relevance (e.g., ICH, PhRMA, ISPE, IQ, Bios, etc.).
- Experience with leading NDA/BLA submission and approvals including global Health Authority Interactions.
- Application of sound and accurate judgment to make timely decisions.
- Demonstrated success in leading complex groups to support operational goals and contribute to the development of global regulatory initiatives.
- Demonstrated organizational leadership skills at both functional and enterprise levels.
- Excellent strategic acumen, collaboration, and communication skills are required.
- Experience supporting multiple regulatory filings including IND/IDE and NDA/BLA and supporting product-related inspections for US and foreign regulatory agencies.
- In-depth understanding of ICH guidelines and GMP requirements for development and manufacturing of small molecules and biologics.
- Proven track record in the successful development and commercialization of device technologies, innovation, and championing business practice improvements.
- Experience leading major initiatives to improve organizational capabilities.
- Demonstrated strategic thinking and influencing skills internally and externally.
- Sound working knowledge of global regulatory requirements for Combination Products/ Devices.
- Excellent leadership, collaboration and communication skills, as well as the proven ability to drive innovation and influence organization change.
- Solid understanding of current industry trends and regulatory expectations associated with QbD, comparability evaluation, scale up, and method and process validation.
Education
- BA/BS or higher in a scientific discipline; advanced degree (MA/MS, PhD, PharmD, MD) preferred.